chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a LPN concerning a 70 year old Caucasian female pt with no known allergies who on 11/10/03 was vaccinated SC in the left arm with a dose of pneumococcal 23v polysaccharide vaccine. On 11/12/03, the pt developed a local site reaction of redness, a swollen arm and tenderness to touch. The left arm became red, warm to touch and edematous with complaints of pain, redness and edema radiating from the shoulder area down to the left elbow. The pt was treated with Duricef 500mg for 7 days. No further complaints were noted. Subsequently, the pt recovered. A product quality complaint was not involved. Additional information is not expected.
Pt recvd vax 210PM & 220PM mom returned pt from waiting room w/ c/o hives & ruddy face & cheeks; coughing, flushing of face, sl localized swelling @ DTP site; poss allerg react; took pt to ER where tx DPH;
This patient had an injection at 2:00 PM on 08/29/2001. She felt funny all afternoon, off balance. She went back to bed, awoke a 3:00 AM having difficulty breathing. Glands, throat all swollen. Tingly fingers and toes. No fever. Stiff neck, headache, queasy stomach, heart beating fast, sore throat when she swallows (hard to swollow), also feels spacey and dizzy.
sore; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore) and CHILLS (chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore) and CHILLS (chills). At the time of the report, MYALGIA (sore) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Fever; Chills; This spontaneous case was reported by a non-health professional and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments  No concomitant medications reported.  No treatment information provided.   Reporter did not allow further contact
atient had vasovagal syncope after receiving vaccines in clinic. Was in clinic with staff approximately 10 mins after vaccines, but upon exiting clinic became unresponsive to mother in parking lot.  Mother caught patient and no injury occured.  Return to clinic where clinic nurse was able to awaken patient with sternal rub and verbal commands.  VS normal. EMS notified and responded but patient was fully awake upon their arrival approximately 5 mins later.  Patient went home with family in stable condition without transfer to hospital.  Discussed with family and they report she is back to baseline status the following morning.
Patient caregiver called on 1/16/23 to let pharmacy know that patient suffered a stroke approximately 34 hours after receiving vaccines.  Stated patient went to the hospital for 3 days and then to rehab.  No other information was provided.
pt recv vax & devel a local raised papular rash around inj site; No further details were provided;
Arm is still a little red; slight throat a little sore; Scratchy voice; Nose running; Soreness; Throat itched; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm is still a little red), OROPHARYNGEAL PAIN (slight throat a little sore), DYSPHONIA (Scratchy voice), RHINORRHOEA (Nose running) and PAIN (Soreness) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 026lL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Arm is still a little red), OROPHARYNGEAL PAIN (slight throat a little sore), DYSPHONIA (Scratchy voice), RHINORRHOEA (Nose running), PAIN (Soreness), THROAT IRRITATION (Throat itched) and CHILLS (Chills). At the time of the report, ERYTHEMA (Arm is still a little red) and OROPHARYNGEAL PAIN (slight throat a little sore) had not resolved, DYSPHONIA (Scratchy voice) and RHINORRHOEA (Nose running) outcome was unknown and PAIN (Soreness), THROAT IRRITATION (Throat itched) and CHILLS (Chills) had resolved.            No concomitant medication was reported. No treatment drug details was reported.   Reporter did not allow further contact
expired vaccine given to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine given to patient) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine given to patient). On 27-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine given to patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was administered with vaccine which was punctured the day before 26-oct-2021 at 3 pm. No adverse reactions were reported as far. Concomitant medications were not provided. Treatment information was not provided.
confused / 'out of it' and did not realize it until later; struggling to find words; Head felt like a 2x4 hit her in the front and back; heart palpitations; dizzy; nauseous; dose number= 1, administration date=26Mar2021; dose number= 2, administration date=26Mar2021; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left leg on 26Mar2021 13:15 (Batch/Lot Number: FR8733) (at the age of 52 years old) as single dose, and the second dose via an unspecified route of administration, administered in left leg on 26Mar2021 (Batch/Lot Number: EW0170) (at the age of 52 years old) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient was not pregnant at the time of vaccination. Concomitant medications included bupropion (BUPROPION) taken for an unspecified indication, start and stop date were not reported; methylphenidate (METHYLPHENIDATE) taken for an unspecified indication, start and stop date were not reported. The patient had known allergies with tetracycline, erythromycin, and biaxin. After the vaccines doses, on 26Mar2021 at 14:00, the patient reported her head felt like a 2x4 hit her in the front and back. She had heart palpitations, and was very dizzy, later becoming very nauseous. She was 'out of it' and did not realize it until later when she felt better. Her partner had to come pick her up, as she was confused and struggling to find words. Patient did not receive treatment for the events. The patient visited her physician. It was reported that dose number 1, administration date was 26Mar2021 13:15; and dose number 2, administration date was 26Mar2021. Outcome of the events was unknown.
2 days after first dose food poisonous, diarrhea, constipation. Mid April fell on right side. I'm trying to get an appointment with GI doctor. Low grade fever everyday since vaccine.
Headache  Severe Chills Nausea  Sore and red at injection site
tested positive for covid in between first and second dose; positive for Covid/ PCR and it tested positive; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EX9231 and expiry date: unknown), via an unspecified route of administration on 20Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient tested positive for covid in between first and second dose on 2021. The physician told the patient to go for a test that day. The first test was a rapid test and it tested negative and the second test was PCR and it tested positive on 2021. So, physician said that patient was positive for Covid. Patient had no reaction, was fine and was doing okay. This coming Thursday, 11Feb2021, patient was scheduled to go for the second shot but she can't go because her husband was sick. She cancelled the appointment but wanted to know how soon will she be able to go get the second shot if she needs the second shot. Outcome of the events was unknown.
Devloped Parsonage Turner Syndrome on 6/23/21 of right arm and hand.  Have limited right hand usage.  Had a Varaciella titer on 6/10/21 for pre-employment showing titer greater than 4000.  Questioned pharmacy about relationship with titer and first shingle shot and she could not answer. I believe my husband had the same thing the year before, however he died of a complication.  I believe he was not duangmnosed correctly.  Per Dr. Parsonage Turner Syndrome is mistaken for cervical disc issues.  I believe he had his second shingle shot just before starting with right shoulder and arm pain too.
I was awakened by severe pain in my left arm. Besides being very painful to touch, it was highly erythematous between shoulder and elbow, top to bottom X's 5 days. Treatment included ice and Tylenol for pain and fever as high as 101.8 X's 3 days.
Bright red spot around the vaccine site then it grew all over arm. Physician diagnosed symptoms as COVID arm.
Vaccine admin on 9/5/12. Small hematemesis on 9/7/12.
For approximately an hour straight, starting about 15 hours after vaccine was administered, I physically could not stop full-body stretching while resting. It was not exactly a muscle spasm, but I was not consciously deciding to stretch. It was in the vein of uncontrollable yawning as a side effect, as it was akin to the type of stretch you'd do when waking up.   Reaction went away after about 2 hours total. I was unable to find any mention of this as a side effect, so I thought it might be best to report it just in case. All other reactions were reactions that were previously recorded and reported as possible side effects.
I noticed the sounds of cicada while laying in bead early in the morning  just prior to the second shot.  I do not recall hearing this  earlier. The sounds have continued .  After reading a little about tinnitus and the sounds that are constantly ringing - I found that is this is a possible side effect of the vaccination
Ran a fever of 101.4.  Spot on arm the size of a baseball that is red, itchy and painful. Feels lethargic. Pt was given Cephalexin 500mg TID x 7 days.
pt recv vax 12AUG97 & dad noted 13AUG97 @ bath 7PM large red area 4x3in in diameter w/fluid filled (clear) lesions near inj site which was hot to touch;same description noted @ time of incident report;
not feeling well, and he needed to go lay down; This is a spontaneous report received from a non-contactable reporter (consumer).  A male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, lot number unknown), for COVID-19 immunisation. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "not feeling well, and he needed to go lay down".  No follow-up attempts are possible; information about the lot/batch number cannot be obtained. No further information is expected.
i started to get a rash on my left shoulder and i didnt know what it was. I thought it was something that happened from what i washed my clothes in. when i woke up that morning it was spreading and they thought it was shingles. i am still dealing with this.
Pain; Swelling; This case was reported by a nurse via sales rep and described the occurrence of pain in an unknown number of patients who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced pain and swelling. On an unknown date, the outcome of the pain and swelling were unknown.   It was unknown if the reporter considered the pain and swelling to be related to Bexsero.  Additional details were provided as follows: This case was reported by the Registered Nurse (RN). The age at vaccination was not reported. The reporter stated that the patients experienced of pain and swelling with the use of Bexsero as a general adverse event they were seeing. The reporter did not agree to follow up.
Pt c/o rash on upper chest (and it was apparent) at 1844. Pt given 50mg benadryl PO X1 at 1844. Pt had no other complaints at this time. Pt rash was monitored until 1858 when her rash seemed to decreased/improve and pt stated she felt well to go home with friend driving.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patients' pertinent medical history and concomitant medications were not reported. On 30-MOV-2015, the patient was vaccinated with a dose of M-M-R II (dose and route of administration were not specified: lot # K011317, expiration date on 13-AUG-2016) that "might" have been improperly stored (it was unknown) if the vaccines underwent a temperature excursion). No adverse effects were reported. This  is one of several reports received from the same reporter. Additional information has been requested.
1st dose over 42 days ago; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (1st dose over 42 days ago) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01321A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal, Gout, Pain, Nausea and Gastrointestinal disorder NOS. Concomitant products included AMLODIPINE for Blood pressure abnormal, PANTOPRAZOLE for Gastrointestinal disorder NOS, ALLOPURINOL for Gout, MEGESTROL for Hormone therapy, MECLIZINE [MECLOZINE] and CYPROHEPTADINE for Nausea, TRAMADOL for Pain, VITAMINS NOS for Vitamin supplementation, HYDROXYCHLOROQUINE for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st dose over 42 days ago). On 04-Mar-2021, PRODUCT DOSE OMISSION ISSUE (1st dose over 42 days ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reportedly, the patient got first dose of vaccine on 04-Mar-2021 however did not receive her second dose as on day of reporting. No treatment information was provided.
Patient passed out approximately 5 minutes after receiving vaccine.  He became more alert after about 1 minute then passed out a second time after approximately 5 minutes.  EMT arrived at this time and took over monitoring the patient.
pt recvd vax & w/in 24 hrs of the inject pt exp viral lung infect w/congestion & cough; condition was treated w/poss Ancef & then several other ATB; sx persisted; 2 months ago recvd 2nd dose of either vax; sx persist;
Patient is a 71 yof who reported to the ED and stated she had been experiencing cough and shortness of breath for the past 8 days, with home COVID-19 test resulting positive 5 days ago.  Per report, the patient arrived to the ED on non-rebreather via EMS with associated oxygen saturation of 97%. She has been maintaining oxygen saturations above 95% on 4L NC and consistently hemodynamically stable and mildly febrile with T. Max 100.1F.  Constitutional: Positive for activity change, appetite change, fatigue and fever. Negative for chills and unexpected weight change.  HENT: Negative for ear pain, hearing loss, sinus pressure, sore throat and trouble swallowing.   Eyes: Negative for visual disturbance.  Respiratory: Positive for cough and shortness of breath.   Cardiovascular: Negative for chest pain and palpitations.  Gastrointestinal: Positive for diarrhea, nausea and vomiting.  Acute hypoxic respiratory failure due to low risk PE and COVID-19 pneumonia, causing deconditioning and weakness, improving - Pt initially presented with shortness of breath and hypoxia, initially thought to be secondary to COVID-19 pneumonia - Completed 5 day course of remdesivir on 11/20 and 10-day course of dexamethasone on 11/25 - CRP has been trending down, yet pt's hypoxia continued to get worse, prompting CT chest w/ contrast 11/24-- showed bilateral central, segmental, and subsegmental pulmonary emboli with large embolism lodged at the bifurcation of the interlobar pulmonary artery. No CT evidence of right heart strain, troponin <100, HR <110, SBP >90 hence classified as low-risk  PLAN - On day of discharge, the pt has been stable for more than 72 hours with oxygen requirements decreasing gradually from 5LPM to 2LPM - She denies shortness of breath and chest pain  Discharge Disposition/Condition Disposition: Home with Home Health Condition: Stable (s/sx potential problems absent or manageable)
Headache; Fatigue; Dizziness; This is a spontaneous report received from a contactable consumer, the parent. A 19-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EP6955), via an unspecified route of administration in the left arm on 20Mar2021 at 11:30 (at the age of 19-years-old), as a single dose for COVID-19 immunisation. Medical history included autism spectrum disorder (Asperger's Syndrome). The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. On 21Mar2021 at 00:00, the patient experienced fatigue, dizziness and headache. The patient did not receive any treatment for the adverse events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, dizziness and headache were recovered on 21Mar2021.  No follow-up attempts are needed. No further information is expected.
Patient received Nasal Flumist, 9 minute after he reported blurred vision and nausea. Patient started vomiting x2, became pale in face. Provider was notified. Patient was taken to ER soon after the event.
she had her first vaccine on 1Aug2021 with some very mild side effects of arm soreness; she had her first vaccine on 1Aug2021 with some very mild side effects of arm soreness and tiredness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (she had her first vaccine on 1Aug2021 with some very mild side effects of arm soreness) and FATIGUE (she had her first vaccine on 1Aug2021 with some very mild side effects of arm soreness and tiredness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Aug-2021, the patient experienced MYALGIA (she had her first vaccine on 1Aug2021 with some very mild side effects of arm soreness) and FATIGUE (she had her first vaccine on 1Aug2021 with some very mild side effects of arm soreness and tiredness). At the time of the report, MYALGIA (she had her first vaccine on 1Aug2021 with some very mild side effects of arm soreness) and FATIGUE (she had her first vaccine on 1Aug2021 with some very mild side effects of arm soreness and tiredness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications was not provided by the reporter Treatment information was not provided   This case was linked to MOD-2021-304259 (Patient Link).
Began soreness in left shoulder down to elbow. Daily, got worse as the day went on. Weeks, months, went to my doctor on April 26th because pain would not go away. She gave me a steroid shot and it was better for 4 weeks, then started to get pain back. Lifting difficult with (L) arm.
aches, headache, tired It lasted about 10 hours.  I was not real sick, just didn't feel well.
Rt arm subcut swelling.  12-4-07 pm-warm, hard to touch & painful, 41 x 27 mm rt. swollen area.
Soreness, hardness, slight swelling, heat, and raised red rash. Soreness, hardness, and swelling and heat went down on day three and four. Rash worsened slightly on day three and mostly gone day 4.
Inadvertently administered improperly stored vaccine; This spontaneous report was received from a medical student referring to a patient of unreported age and gender. The patient's concurrent conditions, pertinent medical history, concomitant therapies, drug reactions or allergies were no reported.   On 14-DEC-2021, the patient was Inadvertently administered improperly stored Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (strength, route of administration, frequency were not reported) for prophylaxis (Product storage error). "Lot number T034980 is an invalid lot number for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II). Lot number T034980 does not match any Company product as confirmed by Lot Verification team.  The vaccine underwent a temperature excursion of 66.66 Fahrenheit for a time period of 13 hours. There was multiple previous temperature excursion.